← Leaderboards
Susan J Ramus
University Of Southern California
$3,904,113
Attributed
$5,926,398
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2013–17$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$5,926,398 · 2
By mechanism
R01$5,926,398 · 2
Top collaborators
- Simon Andrew Gayther5 shared
- Paul Pharoah5 shared
Most similar at University Of Southern California
Same institution · by research overlap
- Robert William Haile$42,901,503
- Simon Andrew Gayther$9,015,265
- Jeffrey S Weber$20,866,039
- Jane C. Figueiredo$16,710,015
- Paul Pharoah$1,833,190
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesGenotypeCollaborationsSample SizeMalignant NeoplasmsInternationalEpithelial Ovarian CancerGeneticMalignant Neoplasm Of OvaryOutcome MeasureSerousSeriesWomanThe Cancer Genome AtlasCandidate Disease GeneEpidemiologyFollow-UpGenetic VariantVariation (Genetics)ResponseSusceptibility GeneMortality Vital StatisticsPublic Health RelevanceCancer Risk
Grant awards (10)
The contribution of rare alleles to ovarian cancer in the population$549,009
R01 · FY2017 · CA
Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer$483,257
R01 · FY2017 · CA · contact PI
The contribution of rare alleles to ovarian cancer in the population$617,338
R01 · FY2016 · CA
Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer$491,893
R01 · FY2016 · CA · contact PI
Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer$687,307
R01 · FY2015 · CA · contact PI
The contribution of rare alleles to ovarian cancer in the population$609,595
R01 · FY2015 · CA
The contribution of rare alleles to ovarian cancer in the population$598,855
R01 · FY2014 · CA
Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer$568,855
R01 · FY2014 · CA · contact PI
Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer$661,659
R01 · FY2013 · CA · contact PI
The contribution of rare alleles to ovarian cancer in the population$658,630
R01 · FY2013 · CA